247 related articles for article (PubMed ID: 20699234)
41. Monoclonal autoantibodies to histones from autoimmune NZB/NZW F1 mice.
Laskov R; Muller S; Hochberg M; Giloh H; Van Regenmortel MH; Eilat D
Eur J Immunol; 1984 Jan; 14(1):74-81. PubMed ID: 6198184
[TBL] [Abstract][Full Text] [Related]
42. Rabbit anti-chromatin antibodies recognize similar epitopes on a histone H1 molecule as lupus autoantibodies.
Morino N; Sakurai H; Yamada A; Yazaki Y; Minota S
Clin Immunol Immunopathol; 1995 Oct; 77(1):52-8. PubMed ID: 7554484
[TBL] [Abstract][Full Text] [Related]
43. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
[TBL] [Abstract][Full Text] [Related]
44. Apoptosis and NET formation in the pathogenesis of SLE.
Bouts YM; Wolthuis DF; Dirkx MF; Pieterse E; Simons EM; van Boekel AM; Dieker JW; van der Vlag J
Autoimmunity; 2012 Dec; 45(8):597-601. PubMed ID: 22913420
[TBL] [Abstract][Full Text] [Related]
45. Mapping of SLE-specific Sm B cell epitopes using murine monoclonal antibodies.
Pruijn GJ; Schoute F; Thijssen JP; Smeenk RJ; van Venrooij WJ
J Autoimmun; 1997 Apr; 10(2):127-36. PubMed ID: 9185874
[TBL] [Abstract][Full Text] [Related]
46. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
48. Autoantibodies to nucleosomes and histone-DNA complexes.
Monestier M
Methods; 1997 Jan; 11(1):36-43. PubMed ID: 8990087
[TBL] [Abstract][Full Text] [Related]
49. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
50. Binding to histone of an anomalous IgG from patients with SLE and drug-induced lupus.
Teodorescu M; Ustiyan V; Russo K; Rubin RL
Clin Immunol; 2004 Feb; 110(2):145-53. PubMed ID: 15003811
[TBL] [Abstract][Full Text] [Related]
51. Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus.
Waisman A; Mozes E
Eur J Immunol; 1993 Jul; 23(7):1566-73. PubMed ID: 8325334
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive Longitudinal Surveillance of the IgG Autoantibody Repertoire in Established Systemic Lupus Erythematosus.
Vordenbäumen S; Brinks R; Hoyer A; Fischer-Betz R; Pongratz G; Lowin T; Zucht HD; Budde P; Bleck E; Schulz-Knappe P; Schneider M
Arthritis Rheumatol; 2019 May; 71(5):736-743. PubMed ID: 30474930
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic histone code and autoimmunity.
Dieker J; Muller S
Clin Rev Allergy Immunol; 2010 Aug; 39(1):78-84. PubMed ID: 19662539
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal autoantibody directed toward histone and capable of inducing LE cell formation.
Miller MM; Goto R; Phillips ML; Klotz JL; Clark SD; Teplitz RL
Hybridoma; 1983; 2(2):201-9. PubMed ID: 6205977
[TBL] [Abstract][Full Text] [Related]
55. Lupus erythematosus cell formation by a monoclonal antibody derived from an autoimmune MRL/Mp-lpr/lpr mouse.
Kanai Y; Yamauchi S; Hashiba-Kanai Y
Immunol Lett; 1989 Jan; 20(1):9-13. PubMed ID: 2469647
[TBL] [Abstract][Full Text] [Related]
56. Triggers for anti-chromatin autoantibody production in SLE.
Dieker JW; van der Vlag J; Berden JH
Lupus; 2002; 11(12):856-64. PubMed ID: 12529051
[TBL] [Abstract][Full Text] [Related]
57. Autoimmunity to isomerized histone H2B in systemic lupus erythematosus.
Doyle HA; Aswad DW; Mamula MJ
Autoimmunity; 2013 Feb; 46(1):6-13. PubMed ID: 22967069
[TBL] [Abstract][Full Text] [Related]
58. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.
Rekvig OP; Van der Vlag J
Semin Immunopathol; 2014 May; 36(3):301-11. PubMed ID: 24763531
[TBL] [Abstract][Full Text] [Related]
59. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
Hristova MH; Stoyanova VS
Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
[TBL] [Abstract][Full Text] [Related]
60. Epitope mapping of histone 5 (H5) with systemic lupus erythematosus, procainamide-induced lupus and hydralazine-induced lupus sera.
Pauls JD; Edworthy SM; Fritzler MJ
Mol Immunol; 1993 Jun; 30(8):709-19. PubMed ID: 7684819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
